Global Induced Pluripotent Stem Cells Production Market 2024-2028

Global Induced Pluripotent Stem Cells Production Market 2024-2028

The induced pluripotent stem cells production market is forecasted to grow by USD 1841.79 mn during 2023-2028, accelerating at a CAGR of 11.66% during the forecast period. The report on the induced pluripotent stem cells production market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising prevalence of several chronic disorders, increasing adoption of ipscs in drug discovery and toxicity screening applications, and growing demand for ipscs for personalized medicines.

Technavio's induced pluripotent stem cells production market is segmented as below:

By End-user

• Hospitals
• Research institutes
• Biotechnology companies
• Others

By Product

• Consumable and kits
• Instrument
• Services and others

By Geographical Landscape

• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the advancements in cell reprogramming techniques as one of the prime reasons driving the induced pluripotent stem cells production market growth during the next few years. Also, emergence of ipsc banks and repositories and growing applications of ipscs in regenerative medicine will lead to sizable demand in the market.

The report on the induced pluripotent stem cells production market covers the following areas:

• Induced pluripotent stem cells production market sizing
• Induced pluripotent stem cells production market forecast
• Induced pluripotent stem cells production market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading induced pluripotent stem cells production market vendors that include Allele Biotechnology and Pharmaceuticals Inc., ALSTEM, Applied Biological Materials Inc., Applied StemCell, ATCC, Axol Biosciences Ltd., Becton Dickinson and Co., Bio Techne Corp., Board of Regents of the University of Wisconsin System, Creative Biolabs, Cyagen Biosciences, Cynata Therapeutics Ltd., Evotec SE, Fate Therapeutics Inc., FUJIFILM Corp., Hitachi Ltd., LIFE and BRAIN GmbH, Lonza Group Ltd., Ncardia Services B.V., REPROCELL Inc., Sartorius AG, STEMCELL Technologies Inc., Takara Bio Inc., and Thermo Fisher Scientific Inc.. Also, the induced pluripotent stem cells production market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.